Transferrin liposomes of docetaxel for brain-targeted cancer applications: formulation and brain theranostics

References

• Anabousi S, Bakowsky U, Schneider M, et al. (2006). In vitro assessment of transferrin-conjugated liposomes as drug delivery systems for inhalation therapy of lung cancer. Eur J Pharm Sci 29:367–74
   PubMed Web of Science ®Google Scholar
• Bao Y, Guo Y, Zhuang X, et al. (2014). D-α-Tocopherol polyethylene glycol succinate-based redox sensitive paclitaxel prodrug for overcoming multidrug resistance in cancer cells. Mol Pharm 11:3196–209
   PubMed Web of Science ®Google Scholar
• Bissery MC, Guenard D, Gueritte-Voegelein F, et al. (1991). Experimental antitumor activity of taxotere (RP 56976, NSC 628503), a taxol analogue. Cancer Res 51:4845–52
   PubMed Web of Science ®Google Scholar
• Burgo LSD, Hernández RM, Orive G, et al. (2014). Nanotherapeutic approaches for brain cancer management. Nanomedicine 10:905–19
   PubMed Web of Science ®Google Scholar
• Daniels TR, Bernabeu E, Rodríguez JA, et al. (2012). The transferrin receptor and the targeted delivery of therapeutic agents against cancer. Biochim Biophys Acta 1820:291–317
   PubMed Web of Science ®Google Scholar
• Feng SS. (2006). New-concept chemotherapy by nanoparticles of biodegradable polymers: where are we now? Nanomedicine (Lond) 1:297–309
   PubMed Web of Science ®Google Scholar
• Gan CW, Feng SS. (2010). Transferrin-conjugated nanoparticles of Poly (lactide)-D-α-tocopheryl polyethylene glycol succinate diblock copolymer for targeted drug delivery across the blood brain barrier. Biomaterials 31:7748–57
   PubMed Web of Science ®Google Scholar
• Gan CW, Chien S, Feng SS. (2010). Nanomedicine: enhancement of chemotherapeutic efficacy of docetaxel by using a biodegradable nanoparticle formulation. Curr Pharm Des 16:2308–20
   PubMed Web of Science ®Google Scholar
• Jones AR, Shusta EV. (2007). Blood–brain barrier transport of therapeutics via receptor mediation. Pharm Res 24:1759–71
   PubMed Web of Science ®Google Scholar
• Kemper EM, Verheij M, Boogerd W, et al. (2004). Improved penetration of docetaxel into the brain by co-administration of inhibitors of P-glycoprotein. Eur J Cancer 40:1269–74
   PubMed Web of Science ®Google Scholar
• Kobayashi T, Ishida T, Okada Y, et al. (2007). Effect of transferrin receptor-targeted liposomal doxorubicin in P-glycoprotein-mediated drug resistant tumor cells. Int J Pharm 329:94–102
   PubMed Web of Science ®Google Scholar
• Kuo YC, Lin PI, Wang CC. (2011). Targeting nevirapine delivery across human brain microvascular endothelial cells using transferrin-grafted poly(lactide-co-glycolide) nanoparticles. Nanomedicine (Lond) 6:1011–26
   PubMed Web of Science ®Google Scholar
• Kutty RV, Chia SL, Setyawati MI, et al. (2015). In vivo and ex vivo proofs of concept that cetuximab conjugated vitamin E TPGS micelles increases efficacy of delivered docetaxel against triple negative breast cancer. Biomaterials 63:58–69
   PubMed Web of Science ®Google Scholar
• Li XM, Ding LY, Xu Y, et al. (2009). Targeted delivery of doxorubicin using stealth liposomes modified with transferrin. Int J Pharm 373:116–23
   PubMed Web of Science ®Google Scholar
• Li Y, He H, Jia X, et al. (2012). A dual-targeting nanocarrier based on poly(amidoamine) dendrimers conjugated with transferrin and tamoxifen for treating brain gliomas. Biomaterials 33:3899–908
   PubMed Web of Science ®Google Scholar
• Liu Y, Li K, Pan J, et al. (2010). Folic acid conjugated nanoparticles of mixed lipid monolayer shell and biodegradable polymer core for targeted delivery of docetaxel. Biomaterials 31:330–8
   PubMed Web of Science ®Google Scholar
• Muthu MS, Singh S. (2009). Targeted nanomedicines: effective treatment modalities for cancer, AIDS and brain disorders. Nanomedicine (Lond) 4:105–18
   PubMed Web of Science ®Google Scholar
• Muthu MS, Kulkarni SA, Xiong J, Feng SS. (2011). Vitamin E TPGS coated liposomes enhanced cellular uptake and cytotoxicity of docetaxel in brain cancer cells. Int J Pharm 421:332–40
   PubMed Web of Science ®Google Scholar
• Muthu MS, Wilson B. (2012). Challenges posed by the scale-up of nanomedicines. Nanomedicine 7:307–9
   PubMed Web of Science ®Google Scholar
• Muthu MS, Kulkarni SA, Raju A, Feng SS. (2012a). Theranostic liposomes of TPGS coating for targeted co-delivery of docetaxel and quantum dots. Biomaterials 33:3494–501
   PubMed Web of Science ®Google Scholar
• Muthu MS, Kulkarni SA, Liu Y, Feng SS. (2012b). Development of docetaxel-loaded vitamin E TPGS micelles: formulation optimization, effects on brain cancer cells and biodistribution in rats. Nanomedicine (Lond) 7:353–64
   PubMed Web of Science ®Google Scholar
• Muthu MS, Feng SS. (2013). Theranostic liposomes for cancer diagnosis and treatment: current development and pre-clinical success Expert Opin. Drug Deliv 10:151–5
   Web of Science ®Google Scholar
• Muthu MS, Leong DT, Mei L, Feng SS. (2014a). Nanotheranostics - application and further development of nanomedicine strategies for advanced theranostics. Theranostics 4:660–77
   PubMed Web of Science ®Google Scholar
• Muthu MS, Mei L, Feng SS. (2014b). Nanotheranostics: advanced nanomedicine for the integration of diagnosis and therapy. Nanomedicine 9:1277–80
   PubMed Web of Science ®Google Scholar
• Muthu MS, Kutty RV, Luo Z, et al. (2015). Theranostic vitamin E TPGS micelles of transferrin conjugation for targeted co-delivery of docetaxel and ultra bright gold nanoclusters. Biomaterials 39:234–48
   PubMed Web of Science ®Google Scholar
• Muthu MS, Sahu AK. Sonali, et al. (2016). Solubilized delivery of paliperidone palmitate by d-alpha-tocopheryl polyethylene glycol 1000 succinate micelles for improved short-term psychotic management. Drug Deliv 23:230–7
   PubMed Web of Science ®Google Scholar
• Ni D, Zhang J, Bu W, et al. (2014). Dual-targeting upconversion nanoprobes across the blood-brain barrier for magnetic resonance/fluorescence imaging of intracranial glioblastoma. ACS Nano 8:1231–42
   PubMed Web of Science ®Google Scholar
• Raju A, Muthu MS, Feng SS. (2013). Trastuzumab-conjugated Vitamin E TPGS liposomes for sustained and targeted delivery of docetaxel. Expert Opin Drug Deliv 10:747–60
   PubMed Web of Science ®Google Scholar
• Schnyder A, Huwyler J. (2005). Drug transport to brain with targeted liposomes. NeuroRx 2:99–107
   PubMedGoogle Scholar
• Singh RP, Sharma G. Sonali, et al. (2016). Transferrin receptor targeted PLA-TPGS micelles improved efficacy and safety in docetaxel delivery. Int J Biol Macromol 83:335–44
   PubMed Web of Science ®Google Scholar
• Sonali, Aggrawal P, Singh RP, et al. (2015). Transferrin receptor targeted Vitamin E TPGS micelles for brain cancer therapy: preparation, characterization and brain distribution in rats. Drug Deliv. [Epub ahead of print]. DOI: 10.3109/10717544.2015.1094681
   PubMedGoogle Scholar
• Song Q, Tan S, Zhuang X, et al. (2014). Nitric oxide releasing D-α-tocopheryl polyethylene glycol succinate for enhancing antitumor activity of doxorubicin. Mol Pharm 11:4118–29
   PubMed Web of Science ®Google Scholar
• Ulbrich K, Hekmatara T, Herbert E, Kreuter J. (2009). Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood–brain barrier (BBB). Eur J Pharm Biopharm 71:251–6
   PubMed Web of Science ®Google Scholar
• Vijayakumar MR, Muthu MS, Singh S. (2013). Co-polymers of poly (lactic acid) and D-α-tocopheryl polyethylene glycol 1000 succinate based nanomedicines: versatile multifunctional platforms for cancer diagnosis and therapy. Expert Opinion on Drug Delivery 10:529–43
   PubMed Web of Science ®Google Scholar
• Weng KC, Noble CO, Sternberg BP, et al. (2008). Targeted tumor cell internalization and imaging of multifunctional quantum dot-conjugated immunoliposomes in vitro and in vivo. Nano Lett 8:2851–7
   PubMed Web of Science ®Google Scholar
• Wen CJ, Zhang LW, Al-Suwayeh SA, et al. (2012). Theranostic liposomes loaded with quantum dots and apomorphine for brain targeting and bioimaging. Int J Nanomedicine 7:1599–611
   PubMed Web of Science ®Google Scholar
• Wen CJ, Sung CT, Aljuffali IA, et al. (2013). Nanocomposite liposomes containing quantum dots and anticancer drugs for bioimaging and therapeutic delivery: a comparison of cationic, PEGylated and deformable liposomes. Nanotechnology 24:1–13
   Google Scholar
• Wilson B, Samanta MK, Santhi K, et al. (2008). Targeted delivery of tacrine into the brain with polysorbate 80-coated poly(n-butylcyanoacrylate) nanoparticles. Eur J Pharm Biopharm 70:75–84
   PubMed Web of Science ®Google Scholar
• Xu Q, Liu Y, Su S, et al. (2012). Anti-tumor activity of paclitaxel through dual-targeting carrier of cyclic RGD and transferrin conjugated hyperbranched copolymer nanoparticles. Biomaterials 33:1627–39
   PubMed Web of Science ®Google Scholar
• Zhang Z, Tan S, Feng SS. (2012). Vitamin E TPGS as a molecular biomaterial for drug delivery. Biomaterials 33:4889–906
   PubMed Web of Science ®Google Scholar
• Zhao J, Mi Y, Feng SS. (2013). Targeted co-delivery of docetaxel and siPlk1 by herceptin-conjugated vitamin E TPGS based immunomicelles. Biomaterials 34:3411–21
   PubMed Web of Science ®Google Scholar
• Zhao L, Feng SS. (2010). Enhanced oral bioavailability of paclitaxel formulated in vitamin E-TPGS emulsified nanoparticles of biodegradable polymers: in vitro and in vivo studies. J Pharm Sci 99:3552–60
   PubMed Web of Science ®Google Scholar
• Zong T, Mei L, Gao H, et al. (2014). Synergistic dual-ligand doxorubicin liposomesImprove targeting and therapeutic efficacy of brain glioma in animals. Mol Pharm 11:2346–57
   PubMed Web of Science ®Google Scholar